J&J lost $36 billion on its earnings day. All 75 S&P 500 financials lost $35 billion on theirs.

Published · 1 min read

healthcareearningsfinancialssp500

On 13 October, the first day of bank earnings season, Johnson & Johnson's 5.7% fall cost more market value than the S&P 500's entire financials sector.

S&P 500 treemap for 13 October 2026: each company sized by market capitalisation and coloured by its move that day

Johnson & Johnson fell 5.73% on Tuesday, 13 October, and took $36.4 billion off the S&P 500. That is more than the index's 75 financial stocks lost between them, $35.3 billion, on the day the big banks opened earnings season.

The S&P 500 itself barely moved. Across all 500 companies the net change was a loss of about $6 billion.

Health care carried the day's losses

Health care was the worst sector on the map, down 1.27% and $84.2 billion. $JNJ was 43% of that. $LLY, $ABBV and $MRK added another $35 billion between them, and only 23 of the sector's 60 stocks rose.

J&J reported third-quarter results before the open. Headlines described an earnings beat and a raised full-year outlook, alongside weak medical device sales and a talc charge. The shares fell on the day of that report.

Market value lost
Johnson & Johnson $36.4B
All 75 S&P 500 financials $35.3B
Whole S&P 500, net $6.3B

A rare move for J&J

The site holds daily closes for $JNJ back to March 2025. In that stretch, Tuesday's 5.73% fall is the second largest one-day drop, behind only the 7.59% fall on 1 April 2025. Before 13 October, J&J had not fallen more than 3.7% in a single session since May 2025.

The banks themselves were mixed. $C fell 5.60% and $WFC 3.10%, while $JPM slipped 0.86% and $GS 0.23%. Citigroup was the largest single loss in financials at $12.4 billion, about a third of J&J's.

See it on the site

Sources

  1. J&J posts weak medical device sales, shares fall — CNBC (13 Oct 2026)
  2. Johnson & Johnson's Upgraded Full-Year Outlook Misses Wall Street Views; Stock Declines — Yahoo Finance (13 Oct 2026)
  3. Johnson & Johnson (JNJ) Q3 Earnings Surpass Estimates — Yahoo Finance (13 Oct 2026)
  4. J&J Takes a $5.5 Billion Talc Charge as MedTech Growth Slows From 7.7% to 2.5% — Yahoo Finance (13 Oct 2026)
  5. Nasdaq ends down as chipmakers fall and bank earnings roll in — Reuters (13 Oct 2026)

New posts as they go up: subscribe to the feed, or turn on the market close email.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙